Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Missing RAF gunner Corrie McKeague's mother has said he had an account on a swingers' website.
"I will work with him where we can, but I just didn't want to go celebrate or legitimise or normalise his presidency," one US lawmaker said.
Former US President George H.W. Bush is in intensive care after suffering from pneumonia, as his wife is admitted as a precaution.